- $80.28m
- -$102.55m
- $0.32m
- 29
- 26
- 55
- 30
Annual balance sheet for Chimerix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 113 | 79 | 88.4 | 217 | 183 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.56 | 0.444 | 0.348 | 1.68 | 1.14 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 118 | 81.7 | 95.8 | 228 | 189 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.25 | 3.04 | 2.66 | 2.19 | 1.71 |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 119 | 84.7 | 101 | 279 | 213 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Current Liabilities | 9.23 | 8.53 | 29.9 | 20.4 | 18.4 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 9.42 | 11.3 | 32.3 | 22.5 | 19.7 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 110 | 73.4 | 68.3 | 257 | 193 |
| Total Liabilities & Shareholders' Equity | 119 | 84.7 | 101 | 279 | 213 |
| Total Common Shares Outstanding |